Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,053 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Digital home-based multidisciplinary cardiac rehabilitation: How to counteract physical inactivity during the COVID-19 pandemic.
Pinto R, Pires ML, Borges M, Pinto ML, Sousa Guerreiro C, Miguel S, Santos O, Ricardo I, Cunha N, Alves da Silva P, Correia AL, Fiúza S, Caldeira E, Salazar F, Rodrigues C, Cordeiro Ferreira M, Afonso G, Araújo G, Martins J, Ramalhinho M, Sousa P, Pires S, Jordão A, Pinto FJ, Abreu A. Pinto R, et al. Among authors: rodrigues c. Rev Port Cardiol. 2022 Mar;41(3):209-218. doi: 10.1016/j.repc.2021.05.013. Epub 2021 Nov 20. Rev Port Cardiol. 2022. PMID: 34840415 Free PMC article.
Tafamidis polyneuropathy amelioration requires modest increases in transthyretin stability even though increases in plasma native TTR and decreases in non-native TTR do not predict response.
Monteiro C, Mesgarzadeh JS, Anselmo J, Fernandes J, Novais M, Rodrigues C, Powers DL, Powers ET, Coelho T, Kelly JW. Monteiro C, et al. Among authors: rodrigues c. Amyloid. 2023 Mar;30(1):81-95. doi: 10.1080/13506129.2022.2126308. Epub 2022 Sep 30. Amyloid. 2023. PMID: 36178172 Free PMC article.
Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individuals.
Miyaji KT, Ibrahim KY, Infante V, Moreira RM, Santos CFD, Belizário JC, Pinto MIM, Marinho AKBB, Pereira JM, Mello LS, Silva VGLD, Sato PK, Strabelli TMV, Ragiotto L, Pacheco PHTM, Braga PE, Loch AP, Precioso AR, Sartori AMC; Study Group; França JÍ, Lima MA, Ando MCS, Rodrigues CCM, Song ATW, Lara AN, Belizário AC, Lima AHSB, Zanetti ACB, Paulo ARDSA, Rosa BMDS, Moraes BDGC, Oliveira BR, Picone CM, Aranda CS, Troli CP, Kokron CM, Terrabuio DRB, Abdala E, David Neto E, Nakanishi ÉYS, Lima FMS, Firmino FB, Santos FBAD, Bacal F, Fatobene G, Santana JO, Kalil J, Barbosa J, Gonçalves LP, Otuyama LJ, Pierrotti LC, Compte LCM, Marinho L, Chaer LN, Seguro LF, Azevedo LS, Ueda MA, Terreri MT, Barros MAMT, Grecco O, Sejas ONE, Musqueira PT, Ito RKL, Teixeira SSS, Fidalgo S, Costa SF, Campos SV, Fernandes TH, Rocha VG, Coelho VC. Miyaji KT, et al. Among authors: rodrigues ccm. Rev Inst Med Trop Sao Paulo. 2025 Jan 20;67:e2. doi: 10.1590/S1678-9946202567002. eCollection 2025. Rev Inst Med Trop Sao Paulo. 2025. PMID: 39841781 Free article. Clinical Trial.
3,053 results